Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: methotrexate

2014 ACR/ARHP Annual Meeting: Fibrotic Complications of Scleroderma

Mary Beth Nierengarten  |  February 1, 2015

Rheumatology experts discuss challenge of selecting appropriate SSc patients with skin fibrosis for treatment

Filed under:ConditionsMeeting ReportsSystemic Sclerosis Tagged with:2014 ACR/ARHP Annual MeetingAC&RAssociation of Rheumatology Professionals (ARP)NierengartenSclerodermaTreatment

2014 ACR/ARHP Annual Meeting: Psoriatic Arthritis

Mary Beth Nierengarten  |  February 1, 2015

Clinical manifestations, approaches to diagnosis, treatment

Filed under:ConditionsMeeting ReportsOther Rheumatic ConditionsPsoriatic Arthritis Tagged with:2014 ACR/ARHP Annual MeetingAC&RAssociation of Rheumatology Professionals (ARP)ClinicalDiagnosisNierengartenPsoriatic ArthritisTreatment

Metabolic Biosensor Implicated in Gout

Lara C. Pullen, PhD  |  February 1, 2015

AMP-activated protein kinase may be link between nutritional excess, inflammation that leads to gout

Filed under:ConditionsGout and Crystalline Arthritis Tagged with:GoutinflammationnutritionPullenrheumatology

Biomarkers in Rheumatoid Arthritis Remain Elusive

Kathy Holliman  |  February 1, 2015

Biomarkers to assess disease progression are in use, but none can predict which therapy will work best for each patient

Filed under:ConditionsRheumatoid Arthritis Tagged with:BiomarkersHollimanRheumatoid arthritis

2014 ACR/ARHP Annual Meeting: Rheumatology Drug Updates, Safety News

Michele B. Kaufman, PharmD, BCGP  |  January 1, 2015

Plus, hydrocodone combination products and brodalumab

Filed under:Biologics/DMARDsConditionsDrug UpdatesGout and Crystalline ArthritisMeeting Reports Tagged with:2014 ACR/ARHP Annual MeetingbrodalumabFDAhydrocodoneKaufmanrheumatologySafety

The ACR/ARHP Member News

Ann-Marie Lindstrom  |  January 1, 2015

Awards, appointments and announcements in the world of rheumatology

Filed under:Profiles Tagged with:ACR/ARHPCareerLindstromrheumatologist

The ACR/ARHP Annual Meeting: Rheumatoid Arthritis Raises Mortality Risk in Women

Kathy Holliman  |  January 1, 2015

Data from Nurses’ Health Study, other clinical trials point to higher risk of respiratory, cardiovascular disease death in women with RA

Filed under:ConditionsMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:2014 ACR/ARHP Annual MeetingcardiovascularHollimanmortalityNurses' Health StudyResearchrespiratoryRheumatoid arthritisWomen

Coding Corner Questions: January

Staff  |  January 1, 2015

Coding cases of drug-induced gout, systemic lupus erythematosus with lung involvement, inflammatory rheumatoid arthritis, osteoporosis

Filed under:Billing/CodingConditionsFrom the CollegeGout and Crystalline ArthritisOsteoarthritis and Bone DisordersPractice Support Tagged with:BillingCodingGoutlungLupusOsteoporosisRheumatoid arthritisrheumatology

Biomarkers to Guide Diagnosis, Treatment of Rheumatic Diseases

Rick Brasington, MD  |  January 1, 2015

Examining the usefulness, drawbacks of current biomarkers in rheumatology and progress to develop better ones

Filed under:ConditionsRheumatoid Arthritis Tagged with:BiomarkersClinicalDr. Richard Brasington Jr.patient careRheumatic DiseaseRheumatoid arthritis

Hepatitis Reaction with Rituximab Sparks Drug Safety Alert

M.J. Burton, MD, K.L. Winthrop, MD, MSPH, & J.W. Baddley, MD, MPH  |  January 1, 2015

The FDA modifies rituximab prescribing information to stress risk of hepatitis B virus reactivation

Filed under:Biologics/DMARDsDrug Updates Tagged with:drugFDAhepatitisrheumatologyrituximabSafetyvirus

  • « Previous Page
  • 1
  • …
  • 78
  • 79
  • 80
  • 81
  • 82
  • …
  • 105
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences